Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 4Medulloblastoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Pinealoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Gliosarcoma 2Glioma, Subependymal 2Glioma 2Glioblastoma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Cognitive Dysfunction 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Retention 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Memory Disorders 1Lung Neoplasms 1

Interventions

Therapeutics 3Yoga 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Methylphenidate 2Educational Status 2Cognitive Behavioral Therapy 2Behavior Therapy 2Zolpidem 1Venlafaxine Hydrochloride 1Valeriana extract 1Uncertainty 1Ultraviolet Therapy 1Tamoxifen 1Saline Solution 1Psychosocial Intervention 1Phototherapy 1Modafinil 1Methods 1Melatonin 1Hypnosis 1Early Intervention, Educational 1Donepezil 1Counseling 1Amplified Fragment Length Polymorphism Analysis 1Acupuncture Therapy 1Actigraphy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sleep Wake Disorders × Donepezil × Clear all
NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Wake Forest University Health Sciences

Phase 2 Completed
62 enrolled 12 charts
Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡